A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch-Reference-Cited by-同舟云学术

A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch

Published:2021-07-08 Issue:9 Volume:37 Page:1645-1655
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Jandhyala Ravi¹²^ORCID

Affiliation:

1. Medialis Ltd, Banbury, United Kingdom of Great Britain and Northern Ireland

2. Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, Faculty of Life Science & Medicine, King’s College London, London, United Kingdom of Great Britain and Northern Ireland

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1947218

Reference18 articles.

1. A systems approach to enhance clinical research and medicines development

2. Investigational Medicinal Product (IMP) Management

3. The Preparation of a Preclinical Dossier to Support an Investigational New Drug (IND) Application and First-in-Human Clinical Trial

4. Drugs, Devices, and the FDA: Part 1

5. The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observed consensus on research priorities for the hypertriglyceridemia patient registry;Current Medical Research and Opinion;2023-08-02

2. Neutral theory: applicability and neutrality of clinical study endpoints where a disease-specific instrument is available;BMC Medical Research Methodology;2023-05-20

3. Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians;Current Medical Research and Opinion;2023-02-10

4. Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model;Current Medical Research and Opinion;2023-02-06

5. Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method;Current Medical Research and Opinion;2023-01-16